NCT06355895

Brief Summary

Standard planning constraints for liver SBRT incorporate strict dose-volume limits for normal liver parenchyma to minimize the risk of radiation-induced liver disease. The presence of diurnal and fasting/fed variations in liver volume therefore carry substantial potential for introducing errors into estimates of dose-volume distribution within normal liver tissue, as well as affecting day-to-day setup fidelity and organ alignment for treatment. This prospective study will examine how diurnal and fast-fed variations in liver volume affect treatment planning for abdominal SBRT.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for not_applicable

Timeline
22mo left

Started May 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress54%
May 2024Mar 2028

First Submitted

Initial submission to the registry

April 2, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 10, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

May 16, 2024

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2028

Last Updated

June 11, 2026

Status Verified

June 1, 2026

Enrollment Period

3.9 years

First QC Date

April 2, 2024

Last Update Submit

June 8, 2026

Conditions

Keywords

Stereotactic Body Radiation Therapy (SBRT)Four-Dimensional Computed Tomography

Outcome Measures

Primary Outcomes (1)

  • Diurnal Difference in Liver Volumes

    Percentage diurnal difference in total liver volumes (change in liver volume), as measured by Stereotactic Body Radiation Therapy (SBRT) planning software.

    At baseline and at 4 hours post intervention

Secondary Outcomes (5)

  • Difference in total liver volume

    At baseline and at 1 hour post intervention

  • Percentage diurnal difference in liver mean dose at V5 Gy

    At baseline and at 1 hour post intervention

  • Percentage diurnal difference in liver mean dose at V15Gy

    At baseline and at 1 hour post intervention

  • Difference in liver mean dose at V15 Gy

    At baseline and at 1 hour post intervention

  • Difference in liver dose at V15 Gy

    At baseline and at 1 hour post intervention

Study Arms (1)

High Carbohydrate Diet

EXPERIMENTAL

1. First scan: after an overnight fast of at least 8 hours using standard radiation oncology CT scan with contrast for treatment planning. 2. Standardized high-carb meal such as 8 ounces of Ensure® nutritional protein shake or a similar meal, immediately following first scan and consumed within 15 minutes. 3. Second scan: within 1 hour of ingestion of the high-carb meal using similar settings to those used in the first scan except for contrast use. 4. Third CT scan at least 4 hours (but no more than 5 hours) after ingestion of high-carb diet on the same day utilizing same set up used in first scan with exception for the use of contrast.

Dietary Supplement: Standardized high-carbohydrate meal

Interventions

8 ounces of Ensure® nutritional protein shake or a similar meal

High Carbohydrate Diet

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Have primary upper abdominal (pancreatic, bile duct, liver) cancer or upper abdominal metastases (liver, adrenal, upper abdominal lymph nodes) planned to undergo SBRT.

You may not qualify if:

  • Had prior Radiation Therapy to the liver
  • Contraindication to receipt of iodinated IV contrast for CT (such as renal insufficiency or allergy that cannot be overcome by premedication)
  • Pregnancy/lactation OR woman of childbearing potential who is unable or unwilling to use adequate contraception during Radiation Therapy.
  • Inability to fast.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UPMC Hillman Cancer Center

Pittsburgh, Pennsylvania, 15232, United States

RECRUITING

Study Officials

  • Susannah Ellsworth, MD

    UPMC Hillman Cancer Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Samantha Demko, BSN

CONTACT

Brieanna Marino, MS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Associate Professor

Study Record Dates

First Submitted

April 2, 2024

First Posted

April 10, 2024

Study Start

May 16, 2024

Primary Completion (Estimated)

March 31, 2028

Study Completion (Estimated)

March 31, 2028

Last Updated

June 11, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Locations